ZENCHI, LLC – Trademark Portfolio

Entity Type: 16

ZENCHI, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ELIX and ZENCHI. The owner is based in New York, NY.

P.O. Box 30409

New York, NY 10011

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ELIXX
ELIXX
Abandoned 2019
ELIX
ELIX
Registered 2019
ZENCHI
ZENCHI
Pending 2018
ZENCHI
ZENCHI
Registered 2017

Trademark Classifications

ZENCHI, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does ZENCHI, LLC have?

ZENCHI, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned.

What trademark classes does ZENCHI, LLC file in?

ZENCHI, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ZENCHI, LLC's most well-known trademarks?

ZENCHI, LLC's registered trademark portfolio includes well-known marks such as ELIX and ZENCHI. These are among 2 currently registered trademarks in the portfolio.

What is ZENCHI, LLC's trademark registration success rate?

ZENCHI, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.